DiabetesPro SmartBrief

Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dHeNCfbwoceAgCgxARpq

June 14, 2012

News for diabetes health professionals

Diabetes in Focus

Omega-3 intake does not lower heart risk in diabetes
A study presented at the ADA 72nd Scientific Sessions revealed omega-3 intake did not lower the rate of cardiovascular events in prediabetes and type 2 diabetes patients. Researchers examined more than 12,500 patients and found that CVD-related deaths occurred in 9.1% of those who took omega-3 supplements and 9.3% of those who took a placebo. The results appear in the New England Journal of Medicine. MedPage Today (free registration) (6/12), HealthDay News (6/11)

Central obesity is not linked to BP outcomes in diabetes
The amount of visceral adipose fat was not associated with primary or secondary outcomes of cardiovascular death, nonfatal myocardial infarction or nonfatal stroke in type 2 diabetes patients who were on intensive blood pressure treatment, a study in Diabetes Care found. The findings were presented at the ADA 72nd Scientific Sessions. MedPage Today (free registration) (6/12)

Salsalate shows A1C benefits in type 2 diabetes patients
Type 2 diabetes patients who took salsalate, an anti-inflammatory agent used for rheumatoid arthritis, attained better A1C levels and had reduced triglyceride levels after 48 weeks compared with those who took a placebo, a study presented at the ADA 72nd Scientific Sessions showed. However, researchers observed weight gain and increased levels of LDL cholesterol and urinary albumin in salsalate-treated patients. Medscape (free registration) (6/11), Endocrine Today (6/12)

Intensive glucose control curbs neuropathy risk in type 1 diabetes
A report in the Cochrane Database of Systematic Reviews showed intensive glucose control resulted in a nearly 2% annual decrease in diabetic neuropathy risk in patients with type 1 diabetes. However, tight glycemic control did not show statistically significant effects in type 2 diabetes patients and was associated with more severe hypoglycemia in both types. MedPage Today (free registration) (6/13)

Novo: Victoza works better than Amylin's Byetta in diabetes
Novo Nordisk said a study confirmed the superiority of its diabetes treatment Victoza over Amylin Pharmaceuticals' Byetta in reducing blood glucose. The research presented at the ADA 72nd Scientific Sessions also confirmed cost-effectiveness and weight loss tied to Victoza, the company said. Reuters (6/11)

Nutrition & Wellness

Smiling adults may promote vegetable intake in children
Children may be encouraged to eat vegetables if they see an adult smiling while eating them, a British study found. The results suggest that adults subconsciously influence children's eating habits through facial expressions, researchers reported in the British Journal of Developmental Psychology. The Telegraph (London) (6/13)

Utah teens eat less nutritious food, get less exercise, survey says
Teenagers in Utah increasingly are sedentary and eat more unhealthy food, according to the CDC's Youth Risk Behavior Survey that also found an uptick in the amount of screen time logged by teens. However, the survey also found teens are consuming slightly more vegetables. The Salt Lake Tribune (Utah) (6/11)

Practice Update

AHRQ helps pharmacies, physician groups implement e-prescribing
The Agency for Healthcare Research and Quality has released two guides for independent pharmacies and physician offices to ease implementation of e-prescribing. The initiative aims to address a digital gap among physician groups, chain pharmacies and independent pharmacies. Modern Healthcare (subscription required) (6/11)

Trends & Technology

HHM system predicts rise, drop in blood glucose levels
A study presented at the ADA 72nd Scientific Sessions revealed the hypoglycemia-hyperglycemia minimizer algorithm -- a system that features continuous subcutaneous insulin infusion pump, continuous glucose monitor and software -- predicted spikes and drops in blood glucose levels and adjusted accordingly. "The successful completion of this study using the HHM system in a human clinical trial setting is a significant step forward in the development of an advanced first-generation artificial pancreas system," a researcher said. PhysiciansBriefing.com/HealthDay News (6/11)

Health spending on track to grow faster than overall economy
A report from Medicare's Office of the Actuary said health care spending will increase 2 percentage points faster than the broader economy and by 2021 account for almost one-fifth of the U.S. economy. The Affordable Care Act is expected to increase spending by $478 billion from 2011 to 2021. Bloomberg Businessweek (6/13), Google/The Associated Press (6/13)

SmartQuote

Give every man thy ear, but few thy voice."

--William Shakespeare,
British playwright

Subscriber Tools

Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise

Account Director: Aaron Kern (202) 407-7866